Product Information
PHENOBARBITAL 30 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.1344 per EA under NDC 16571067201. Its NADAC has been published 264 times since Aug 4, 2021.
Strength
30 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571067201
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
PHENOBARBITALApproval Type
Unapproved
On Market Since
11/1/2020
Price Statistics
The NADAC for PHENOBARBITAL 30 MG TABLET has been published 264 times since Aug 4, 2021, and over the history we have for it it has declined 41.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1344 per EA |
|---|---|
| All-time high | $0.2632 (Sep 15, 2021) |
| All-time low | $0.0913 (Nov 20, 2024) |
| 52-week high | $0.1735 |
| 52-week low | $0.1206 |
| Median price | $0.1674 |
| Average price | $0.1720 |
| Largest weekly change | -45.1% (Nov 20, 2024) |
| Weeks tracked | 264 |
| Tracking since | Aug 4, 2021 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PHENOBARBITAL 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 30 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.1344 per EA (NDC 16571067201), effective Aug 19, 2026.
How has the price of PHENOBARBITAL 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for PHENOBARBITAL 30 MG TABLET has declined 41.8%. It has been tracked across 264 weekly CMS publications since Aug 4, 2021.
What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 30 MG TABLET?
Since Aug 4, 2021, the NADAC for PHENOBARBITAL 30 MG TABLET has ranged from a low of $0.0913 (Nov 20, 2024) to a high of $0.2632 (Sep 15, 2021), with a median of $0.1674 per EA.
Are there cheaper alternatives to PHENOBARBITAL 30 MG TABLET?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as PHENOBARBITAL 30 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures PHENOBARBITAL 30 MG TABLET?
PHENOBARBITAL 30 MG TABLET (NDC 16571067201) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.